Back to the Future: Ortega Indica – The Perfect Soporific Ortega Indica is the first medical strain officially classified as such by Dutch Passion. Its pedigree dates back to original stock from breeder Neville’s legendary Seed Bank of the eighties, consisting of the original Ortega Indica and Northern Lights #1. Henk from Dutch passion reports…
Early XXX has been developed to grow outdoors in northern Europe and has a great number of desirable traits It is not always easy to grow a plant outside, especially when you live in a cold country. In northern Europe, for example, the summers are not particularly hot and the autumn, with its loads of…
The endocannabinoid system (ECS) primarily consists of cannabinoid receptors (CBRs), endogenous ligands, and enzymes for endocannabinoid biosynthesis and inactivation. Given the varying and sometimes limited efficacy of current medical therapies for diseases of the esophagus, further understanding and investigation into the interplay of the ECS on esophageal health and disease may present new therapeutic modalities that may help advance current treatment options.
Cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC) have well documented immunomodulatory effects in vitro, but not following oral administration in humans. Immune cells from MS patients were more susceptible to the immunosuppressive effects of cannabinoids than those from healthy volunteers or cancer patients. Administering cannabinoids with a high-fat meal or in lipid-based formulations has the potential to be a therapeutic approach to improve the treatment of MS, or indeed other autoimmune disorders.
